V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260006631 | 260011329 | 1.6 | 90.9 | Disease modification (D) | null | 2014-08-14 | BENDAMUSTINE + RITUXIMAB | N | N | 260024249 | BENDAMUSTINE + RITUXIMAB |
| 260006632 | 260004819 | 1.58 | 65 | Disease modification (D) | 2015-06-30 | 2015-06-30 | BENDAMUSTINE + RITUXIMAB | N | N | 260024250 | BENDAMUSTINE + RITUXIMAB |
| 260006633 | 260004819 | 1.73 | 98.5 | Disease modification (D) | 2015-04-05 | 2015-04-12 | Bendamustine+Rituximab (1st Course) | 02 | N | 260024250 | BENDAMUSTINE + RITUXIMAB |
| 260006634 | 260004820 | 1.75 | 84.5 | Palliative (P) | 2015-04-26 | 2015-04-27 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024252 | BENDAMUSTINE + RITUXIMAB |
| 260006635 | 260004821 | 1.75 | 96 | Palliative (P) | 2017-03-27 | 2017-03-27 | Bendamustine+Rituximab (1st Course) | 2 | N | 260024253 | BENDAMUSTINE + RITUXIMAB |
| 260006636 | 260004822 | 0 | 121 | Unknown (U) | 2015-08-04 | 2015-08-07 | Bendamustine+Rituximab (1st Course) | N | N | 260024254 | BENDAMUSTINE + RITUXIMAB |
| 260006637 | 260004822 | 1.54 | 76 | Disease modification (D) | 2014-10-22 | 2014-10-27 | BENDAMUSTINE + RITUXIMAB | N | N | 260024254 | BENDAMUSTINE + RITUXIMAB |
| 260006638 | 260004823 | 1.75 | 98.4 | Disease modification (D) | 2017-07-07 | 2017-07-07 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024261 | BENDAMUSTINE + RITUXIMAB |
| 260006639 | 260004823 | null | 73.8 | null | 2017-09-13 | 2017-09-22 | Bendamustine+Rituximab (1st Course) | null | N | 260024261 | BENDAMUSTINE + RITUXIMAB |
| 260006640 | 260004824 | 1.72 | 74.4 | Disease modification (D) | 2014-05-12 | 2014-05-25 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024264 | BENDAMUSTINE + RITUXIMAB |
| 260006641 | 260004825 | 1.76 | 118.4 | Adjuvant (A) | 2015-10-11 | 2015-10-11 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024265 | BENDAMUSTINE + RITUXIMAB |
| 260006642 | 260004825 | 1.86 | null | null | 2016-02-23 | 2016-02-23 | BENDAMUSTINE + RITUXIMAB | N | N | 260024265 | BENDAMUSTINE + RITUXIMAB |
| 260006643 | 260004826 | 1.66 | 62.2 | Curative (C) | 2014-11-10 | 2014-11-10 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024268 | BENDAMUSTINE + RITUXIMAB |
| 260006644 | 260004826 | 1.68 | 103 | Palliative (P) | 2015-11-10 | 2015-11-12 | Bendamustine+Rituximab (1st Course) | 2 | N | 260024268 | BENDAMUSTINE + RITUXIMAB |
| 260006645 | 260004827 | 1.77 | 102 | Curative (C) | 2013-05-03 | 2013-05-09 | BENDAMUSTINE + RITUXIMAB | 02 | null | 260024272 | BENDAMUSTINE + RITUXIMAB |
| 260006646 | 260004827 | 1.58 | null | Curative (C) | null | 2017-07-13 | BENDAMUSTINE + RITUXIMAB | N | null | 260024272 | BENDAMUSTINE + RITUXIMAB |
| 260006647 | 260004828 | 1.55 | 69 | Disease modification (D) | 2017-09-29 | 2017-10-03 | BENDAMUSTINE + RITUXIMAB | N | N | 260024276 | BENDAMUSTINE + RITUXIMAB |
| 260006648 | 260004828 | 1.75 | 84.4 | Curative (C) | 2013-07-22 | 2013-07-23 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024276 | BENDAMUSTINE + RITUXIMAB |
| 260006649 | 260004828 | null | 87 | null | 2016-10-19 | 2016-11-02 | BENDAMUSTINE + RITUXIMAB | Y | N | 260024276 | BENDAMUSTINE + RITUXIMAB |
| 260006650 | 260017302 | 1.69 | 44.6 | Disease modification (D) | 2015-08-04 | 2015-08-07 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260024285 | BENDAMUSTINE + RITUXIMAB |
| 260006651 | 260004829 | 1.7 | 68.5 | Curative (C) | 2015-07-25 | 2015-07-25 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024286 | BENDAMUSTINE + RITUXIMAB |
| 260006652 | 260004829 | 1.95 | 98.4 | Disease modification (D) | 2017-12-13 | 2017-12-17 | BENDAMUSTINE + RITUXIMAB | N | N | 260024286 | BENDAMUSTINE + RITUXIMAB |
| 260006653 | 260004830 | null | null | null | 2016-10-11 | 2016-10-14 | Bendamustine+Rituximab(Sub Courses) | 02 | null | 260024290 | BENDAMUSTINE + RITUXIMAB |
| 260006654 | 260004830 | 1.55 | 40.3 | Curative (C) | 2018-01-18 | 2018-02-02 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024290 | BENDAMUSTINE + RITUXIMAB |
| 260006655 | 260004830 | 1.92 | 75.6 | Disease modification (D) | 2015-08-04 | 2015-08-04 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024290 | BENDAMUSTINE + RITUXIMAB |
| 260006656 | 260004831 | null | null | null | 2015-10-30 | 2015-11-10 | BENDAMUSTINE + RITUXIMAB | N | N | 260024300 | BENDAMUSTINE + RITUXIMAB |
| 260006657 | 260004831 | 1.77 | 70 | Radical (R) | 2013-02-13 | 2013-02-15 | BENDAMUSTINE + RITUXIMAB | N | N | 260024300 | BENDAMUSTINE + RITUXIMAB |
| 260006660 | 260004833 | 1.8 | 74.4 | Palliative (P) | 2015-08-07 | 2015-08-21 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024310 | BENDAMUSTINE + RITUXIMAB |
| 260006661 | 260004833 | null | null | null | 2015-06-09 | 2015-06-11 | Bendamustine+Rituximab (1st Course) | 02 | N | 260024310 | BENDAMUSTINE + RITUXIMAB |
| 260006662 | 260004833 | 1.68 | 104.4 | Palliative (P) | 2014-02-21 | 2014-02-21 | BENDAMUSTINE + RITUXIMAB | N | N | 260024310 | BENDAMUSTINE + RITUXIMAB |
| 260006663 | 260004834 | 1.86 | 71 | Disease modification (D) | 2016-07-14 | 2016-07-21 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024314 | BENDAMUSTINE + RITUXIMAB |
| 260006664 | 260004834 | 1.6 | 69 | Palliative (P) | 2018-02-10 | 2018-02-16 | Bendamustine+Rituximab (1st Course) | 02 | N | 260024314 | BENDAMUSTINE + RITUXIMAB |
| 260006665 | 260004835 | 1.72 | 73.8 | Curative (C) | 2018-06-04 | 2018-06-04 | Bendamustine+Rituximab (1st Course) | N | N | 260024316 | BENDAMUSTINE + RITUXIMAB |
| 260006666 | 260004835 | 1.45 | 100 | Palliative (P) | 2018-02-05 | 2018-02-05 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260024316 | BENDAMUSTINE + RITUXIMAB |
| 260006669 | 260011344 | 1.61 | 51 | Palliative (P) | 2014-07-19 | 2014-07-23 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024323 | BENDAMUSTINE + RITUXIMAB |
| 260006670 | 260004838 | 1.75 | 87.7 | Palliative (P) | 2016-10-01 | 2016-10-01 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024324 | BENDAMUSTINE + RITUXIMAB |
| 260006671 | 260004838 | 1.65 | 63 | Disease modification (D) | 2015-01-28 | 2015-02-01 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024324 | BENDAMUSTINE + RITUXIMAB |
| 260006672 | 260004839 | 1.56 | 55.4 | Curative (C) | 2015-12-26 | 2015-12-27 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260024327 | BENDAMUSTINE + RITUXIMAB |
| 260006673 | 260004839 | 1.52 | 90 | Disease modification (D) | 2016-12-05 | 2016-12-06 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024327 | BENDAMUSTINE + RITUXIMAB |
| 260006674 | 260004840 | 1.74 | 77 | Palliative (P) | 2016-02-12 | 2016-02-23 | Bendamustine+Rituximab(Sub Courses) | N | N | 260024329 | BENDAMUSTINE + RITUXIMAB |
| 260006675 | 260004840 | 1.74 | 66 | null | 2016-02-03 | 2016-02-12 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260024329 | BENDAMUSTINE + RITUXIMAB |
| 260006676 | 260004841 | 1.6 | 77 | Palliative (P) | 2014-02-20 | 2014-02-21 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024334 | BENDAMUSTINE + RITUXIMAB |
| 260006677 | 260004841 | 1.7 | 64.9 | Disease modification (D) | 2016-07-28 | 2016-09-28 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024334 | BENDAMUSTINE + RITUXIMAB |
| 260006678 | 260004842 | null | null | null | 2017-01-09 | 2017-01-11 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024336 | BENDAMUSTINE + RITUXIMAB |
| 260006679 | 260004842 | 1.55 | 60.5 | Palliative (P) | 2018-01-05 | 2018-01-05 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024336 | BENDAMUSTINE + RITUXIMAB |
| 260006680 | 260004843 | 1.59 | 85.6 | Disease modification (D) | 2017-06-23 | 2017-06-28 | Bendamustine+Rituximab (1st Course) | 2 | N | 260024340 | BENDAMUSTINE + RITUXIMAB |
| 260006681 | 260004843 | 1.79 | 73 | Palliative (P) | 2016-05-04 | 2016-05-05 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024340 | BENDAMUSTINE + RITUXIMAB |
| 260006682 | 260004843 | 1.62 | 59.6 | Palliative (P) | 2016-01-31 | 2016-03-08 | BENDAMUSTINE + RITUXIMAB | N | N | 260024340 | BENDAMUSTINE + RITUXIMAB |
| 260006683 | 260004844 | 1.73 | 95.5 | Disease modification (D) | 2017-12-12 | 2018-01-05 | Bendamustine+Rituximab (1st Course) | N | N | 260024347 | BENDAMUSTINE + RITUXIMAB |
| 260006684 | 260004845 | 1.67 | null | Adjuvant (A) | 2015-03-16 | 2015-03-29 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024352 | BENDAMUSTINE + RITUXIMAB |